Shikoku Cancer Center

Matsuyama, Ehime 791-0281

1 studies enrolling now · 7 studies all time

What they study most

Carcinoma, Pancreatic Ductal, Metastatic Colon Cancer, Metastatic Colorectal Cancer, Ovarian Cancer, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC, Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Solid Tumor, Squamous Cell Carcinoma (SCC)

Studies at this site

• A Study of ASP3082 in Adults With Advanced Solid Tumors — Recruiting now
• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• Study of Cemiplimab in Adults With Cervical Cancer — Completed
• A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer — Completed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed
• Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early